Since our founding in 1997, we have deployed over $2 billion of equity capital on behalf of our funds and co-investors in 40 investments across Asia. Below is a selected list of previous and current investments.
Arysta LifeScience Corporation (“Arysta”), headquartered in Japan, is the world’s largest privately held agrochemical company. Arysta specializes in the development, registration, formulation, marketing and distribution of conventional crop protection products such as herbicides, insecticides, fungicides and growth regulators, which account for approximately 90% of the Company’s revenues. Arysta also develops and distributes life sciences products targeting animal health, human health, and plant nutrition. Arysta has an extensive product portfolio comprising more than 150 products in over 125 countries around the world.
- Financial & Business Services
- Japan, Regional/Cross-Border, SE Asia
Asia Project Holdings was a joint venture with Fuji Bank (now Mizuho Bank) of Japan to invest in a portfolio of Southeast Asian project finance loans. The loans were senior debt securities primarily in natural resources, petrochemical and other industrial projects, with world-class multinational sponsors and strong risk-mitigating structures.
Asurion Asia Pacific was a joint venture between Olympus Capital Asia and Asurion Corporation (“Asurion”), a global provider of consumer technology protection services. The joint venture was formed to introduce Asurion’s business model in Asia. Today Asurion offers technical support to help customers derive optimum benefit from the usage of electronics, mobile security to help ensure content privacy, and rapid replacement of lost, stolen, damaged or malfunctioning devices.
China Minzhong Food Corporation Ltd. (“China Minzhong”) is a leading, internationally accredited, integrated vegetable processor located in China. Operating since 1971, China Minzhong has five cultivation bases in the PRC, and since inception has distributed its products to 26 different countries across four continents. Its key products consist of fresh vegetable produce and more than 100 types of processed vegetables, which include air-dried, freeze-dried, fresh-packed and brined products. China Minzhong’s products have been awarded numerous international and domestic awards and certifications, including the ISO22000 (which incorporates the HACCP standards) and ISO 9001 standards.
China Zhongwang Holdings Ltd. (“China Zhongwang”) is the world’s second largest and Asia’s largest producer and developer of industrial aluminum extrusion products. China Zhongwang is principally engaged in the production of high precision, large-section and high value-added industrial aluminum extrusion products which are widely used in the transportation, machinery equipment and electric power engineering sectors. Its product applications encompass railway passenger compartments and cargo carriages, metropolitan subway and light rail, automobiles, heavy trucks, vessels, aviation, and aerospace.
Clearwater Capital Partners (“Clearwater”), founded by three principals with extensive experience in Asian debt markets, is an investment management company focusing on Asian distressed debt securities. Olympus sponsored the formation of Clearwater and its first investment vehicle. Olympus Capital Asia was the largest investor in Clearwater’s first fund and owned a minority stake in the management company. Olympus subsequently invested into other investment vehicles managed by Clearwater.
DM Healthcare (“DM Healthcare” or the “Company”) is an Indian company that is a leading healthcare services provider in the Gulf Cooperation Council (“GCC”) countries and India. The Company runs clinics, pharmacies and hospitals in several GCC countries (the United Arab Emirates, Saudi Arabia, Oman and Qatar) and owns secondary and tertiary care hospitals in India. DM Healthcare currently has 1400 beds under operation and plans to commission 1300 beds in the next three years, predominantly in India.
HDFC Bank is one of India's premier private sector banks. The bank’s founding sponsor is the Housing Development Finance Corporation, India’s leading mortgage lender with an outstanding franchise among consumers in India’s financial services sector. HDFC Bank offers a wide range of commercial and transactional banking services and treasury products to wholesale and retail customers.
Huaxia Dairy Farm Ltd. (“Huaxia”) operates one of the largest progressive corporate dairy farms in China and is a leading producer of high-quality raw milk in the Beijing-Tianjin region, based in Sanhe of Hebei province, China. Established in 2004, the Company is known for its deployment of modern advanced technology, resulting in an outstanding safety record and quality milk that surpasses international standards. Apart from supplying dairy processing companies with milk, Huaxia also has a retail presence with Wondermilk and Wonderyoghurt. Through collaborative partnerships with strategic industry players both in China and overseas, Huaxia Dairy aims to contribute to: the advancement of the dairy industry in China through various aspects of modern technology transfer; raising the standards of animal healthcare, veterinary practice and training; improving dairy herd genetics and feed structure; and introducing precision laboratory testing and traceability.
At the time of Olympus Capital Asia’s investment, Korea Exchange Bank Credit Services Co., Ltd. (“KEBCS”) was the credit card subsidiary of Korea Exchange Bank, one of the leading commercial banks in Korea. KEBCS was among the top credit card issuers in Korea and its main credit products included general purchases, installment finance, cash advances, revolving credit, and personal loans. Since Olympus’ investment, KEBCS has merged into Korea Exchange Bank.